https://orcid.org/0000-0002-2380-9983
References
- Moingeon P, Kuenemann M, Guedj M. Artificial intelligence-enhanced drug design and development: toward a computational precision medicine. Drug Discov Today. 2022;27(1):215–222. doi: 10.1016/j.drudis.2021.09.006
- Sanz I, Lund F. Complexity and heterogeneity - the defining features of autoimmune diseases. Curr Opin Immunol. 2019;61:iii–vi. doi: 10.1016/j.coi.2019.11.006
- Buckley C, Chernajovsky L, Chernajovsky Y, et al. Immune-mediated inflammation across disease boundaries: breaking down research silos. Nat Immunol. 2021;22(11):1344–1348. doi: 10.1038/s41590-021-01044-7
- Agrebi S, Larbi A. Use of artificial intelligence in infectious diseases. Artif Intel In Precis Health. 2020:415–438. doi: 10.1016/B978-0-12-817133-2.00018-5 Epub 2020 Mar 13. PMCID: PMC7153335.
- Desvaux E, Hamon A, Hubert S, et al. Network computing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19. PLOS ONE. 2022;16(7):e0254374. doi: 10.1371/journal.pone.0254374
- Barturen G, Babaei S, Català‐Moll F, et al. Integrative analysis reveals a molecular stratification of systemic autoimmune diseases. Arthritis Rheumatol. 2021;73:1073–1085. doi: 10.1002/art.41610
- Guthridge JM, Wagner CA, James JA. The promise of precision medicine in rheumatology. Nat Med. 2022;28(7):1363–1371. doi: 10.1038/s41591-022-01880-6
- Lee H-S, Cleynen I. Molecular profiling of inflammatory bowel disease: is it ready for use in clinical decision-making? Cells. 2019;8(6):535. doi: 10.3390/cells8060535
- Moingeon P. Artificial intelligence-driven drug development against auto-immune diseases. Trends Pharmacol Sci. 2023;44(7):411–424. doi: 10.1016/j.tips.2023.04.005
- Shamji M, Ollert M, Adcock IM, et al. EAACI guidelines on environmental science in allergic diseases and asthma – Leveraging artificial intelligence and machine learning to develop a causality model in exposomics. Allergy. 2023;16(7):1742–1757. doi: 10.1111/all.15667.hal-04144248
- Rider NL, Coffey M, Kurian A, et al. A validated artificial intelligence-based pipeline for population-wide primary immunodeficiency screening. J Allergy Clin Immunol. 2023 Jan;151(1):272–279. doi: 10.1016/j.jaci.2022.10.005 Epub 2022 Oct 13. PMID: 36243223.
- El Alaoui Y, Elomri A, Qaraqe M, et al. A review of artificial intelligence applications in hematology management: current practices and future prospects. J Med Internet Res. 2022 Jul 12;24(7):e36490. doi: 10.2196/36490 PMID: 35819826; PMCID: PMC9328784.
- Moingeon P, Chesnel M, Rousseau C, et al. Virtual patients, digital twins and causal disease models: paving the ground for virtual clinical studies. Drug Discov Today. 2023;28(7):103605. doi: 10.1016/j.drudis.2023.103605
- Mason DM, Friedensohn S, Weber CR, et al. Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning. Nat Biomed Engineer. 2021;5(6):600–612. doi: 10.1038/s41551-021-00699-9
- Desvaux E, Aussy A, Hubert S, et al. Model-based computational precision medicine to develop combination therapies for autoimmune diseases. Exp Rev Clin Immunol. 2022;18:47–56. doi: 10.1080/1744666X.2022.2012452